Fexotine should be administered to pregnant women, nursing women and children under 6 months with caution.
Stop using Fexotine and consult physicians when cardiac arrhythmia occur.
Caution should be exercised when Fexotine is administered to the patients with renal impairment.
Co-administration of Fexotine with Macrolides group eg, Erythromycin or Imidazole group eg, Ketoconazole led to increased plasma levels of fexofenadine hydrochloride.